Alterity Therapeutics Ltd News

Alterity Therapeutics Ltd: Alterity Announces Publication On ATH434 Mechanism of Action

06:17

Alterity Therapeutics Ltd: ATH to Participate in 2024 Maxim Healthcare Virtual Summit

Oct 14 08:07

Alterity Therapeutics Ltd: Alterity Presents Data Describing Neuroprotection of ATH434

Oct 11 06:36

Alterity Therapeutics Ltd: Change of Share Registry

Oct 4 11:05

Alterity Therapeutics Ltd: Alterity Data Presentations at MDS Congress Raises Profile

Oct 2 09:43

Alterity Therapeutics Ltd: Alterity Therapeutics Filed Form 20-F and XBRL data with SEC

Sep 30 11:32

Alterity Therapeutics Ltd: ATH Appoints Abby Macnish Niven as Chief Financial Officer

Sep 30 07:00

Alterity Therapeutics Ltd: Appendix 4G

Sep 26 11:20

Alterity Therapeutics Ltd: Corporate Governance Statement

Sep 26 11:15

Alterity Therapeutics Ltd: Alterity to Deliver Multiple Presentations at MDS Congress

Sep 23 07:33

Alterity Therapeutics Ltd: Change of Director's Interest Notice - BM / PM

Sep 20 06:17

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 31 06:12

Alterity Therapeutics Ltd: Alterity Therapeutics to Present at MST Financial Webinar

Jul 24 09:15

Alterity Therapeutics Ltd: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial

Jul 17 08:20

Alterity Therapeutics Ltd: Trading Halt

Jul 15 07:25

Alterity Therapeutics Ltd: Alterity to Present at Hidden Gems in Life Sciences Webinar

Jun 13 06:42

Alterity Therapeutics Ltd: Phase 2 DMC Recommends Continuing Clinical Trial as Planned

May 8 06:27

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 07:06

Alterity Therapeutics Ltd: Alterity Presents New Data on ATH434

Apr 29 06:41

Alterity Therapeutics Ltd: Alterity Parkinson's and MSA Data Featured at AAN Meeting

Apr 17 06:48